Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

GSK signs oncology deal with UK biotech

May 18, 2009 Research and Development, Sales and Marketing GSK, Oxford Biotherapeutics

GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …
News

Sanofi-Aventis signs deal with Japanese biotech

May 15, 2009 Research and Development, Sales and Marketing Sanofi-Aventis

Sanofi-Aventis has signed an early-stage research deal with biotech Kyowa Hakko Kirin, and will receive rights to its preclinical stage …
News

NHS generic drive saves

May 14, 2009 Sales and Marketing NHS

The NHS saved £394 million last year by prescribing cheaper generic medicines, according to an academic study. The Department of …
News

Boehringer signs diabetes and obesity deal

May 14, 2009 Research and Development, Sales and Marketing Boehringer

Boehringer Ingelheim has signed a deal with German biopharma firm DeveloGen to research and develop treatments for diabetes and obesity. …
News

AstraZeneca buoyed as Brilinta tops Plavix in trial

May 13, 2009 Research and Development, Sales and Marketing AZ, Brillinta

AstraZeneca has been lifted by clinical results indicating its antiplatelet drug Brilinta outperformed Sanofi-Aventis/Bristol-Myers Squibb’s Plavix – currently the world’s …
News

GSK boosts stake in Aspen

May 12, 2009 Sales and Marketing GSK, generics

GlaxoSmithKline has extended its stake in the South African generics company Aspen to a 16% shareholding. In return it will …
News

Working Life: Nick Rodgers

May 12, 2009 Sales and Marketing WL, Working Life, marketing, product manager

How did you find your way into your current role?I started my pharma career at Schering Healthcare as a representative …
Feature

GSK claims superiority for Cervarix in head-to-head trial

May 11, 2009 Research and Development, Sales and Marketing GSK, vaccines

GlaxoSmithKline says a new study shows its cervical cancer vaccine Cervarix induces a higher immune response compared to rival Gardasil. …
News

Advertising regulator clears ‘dead rat’ cinema ad

May 11, 2009 Sales and Marketing counterfeits

Pfizer's hard-hitting advert about the dangers of using counterfeit medicines did not breach advertising regulations, according to the Advertising Standards …
News

Boost for UK cancer care services

May 8, 2009 Sales and Marketing Cancer, NHS

News

Pharma must go further with its collaborations

May 8, 2009 Research and Development, Sales and Marketing pwC, strategy

Pharma companies will soon have to start collaborating with companies outside the healthcare sector.The global economic situation will make this …
News

Servier signs drug discovery deal with Vernalis

May 7, 2009 Research and Development, Sales and Marketing Servier, Vernalis

Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …
News

NICE rejects Nexavar for liver cancer

May 7, 2009 Research and Development, Sales and Marketing Bayer, NICE, Nexavar

NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …
News

Avastin approved for aggressive brain tumour

May 7, 2009 Sales and Marketing GBM, avastin

 Roche has gained US approval for Avastin in people with the aggressive brain cancer glioblastoma multiforme (GBM). The drug can …
News

Novo Nordisk plans summer launches for new diabetes drug

May 7, 2009 Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes

Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026